---
title: "港怡醫院和香港中文大學醫院正在以組織碎化技術進行胰臟癌臨床試驗。 — post author — DecisionGateway"
description: "statement by post author, recorded 2026-11-11 — verbatim quote and source citation."
canonical_url: "https://dgw.tmarket.io/claims/01a1e96c-97ee-7e95-a08b-78d7b30f2e7c"
meta:
  "og:description": "statement by post author, recorded 2026-11-11 — verbatim quote and source citation."
  "og:image": "https://dgw.tmarket.io/og.jpg"
  "og:image:alt": "White network of connected nodes crossed by a timeline on black"
  "og:image:height": "1024"
  "og:image:width": "1024"
  "og:title": "港怡醫院和香港中文大學醫院正在以組織碎化技術進行胰臟癌臨床試驗。 — post author — DecisionGateway"
  "twitter:image": "https://dgw.tmarket.io/og.jpg"
---

> Index of every page on this site: [llms.txt](https://dgw.tmarket.io/llms.txt)

statementSaid on 2026-11-11

# **港怡醫院和香港中文大學醫院正在以組織碎化技術進行胰臟癌臨床試驗。**

A statement by post author, said on 2026-11-11. Statements are as reported by the cited publishers — not verified by DecisionGateway.

> *港怡醫院和香港中文大學醫院正在以組織碎化技術進行胰臟癌臨床試驗*

rthk\_new\_cPublished 2026-11-11 [ Read source](https://t.me/rthk_new_c/401274)

## **Discussion**

## **Related claims**

[**此舉令香港成為亞洲首個推行組織碎化技術（Histotripsy）腎臟癌臨床試驗的城市。**李嘉誠基金會 · statement](https://dgw.tmarket.io/claims/01a1e96c-97d2-7460-b264-233588f7debe) [**港怡自今年3月31日開始，已成功完成20宗胰臟腫瘤個案。**post author · statement](https://dgw.tmarket.io/claims/01a1e96c-9802-7563-9c4b-0a2374795ec8) [**Hong Kong has launched Asia's first kidney cancer clinical trial.**headline · statement](https://dgw.tmarket.io/claims/01a1ecba-5319-740a-b41b-f0f32d29c80b) [**李嘉誠將向香港中文大學醫院、港怡醫院及養和醫院提供30個臨床試驗名額。**李嘉誠基金會 · commitment](https://dgw.tmarket.io/claims/01a1e96c-97c1-7d94-93bc-408385aeabfd) [**截至目前，累計與43國的48家醫院建立對口合作關係，共同開展聯合科研和臨牀試驗。**梁林沖 · statement](https://dgw.tmarket.io/claims/01a1e747-c4d0-742a-a7d0-a5cee5f5a1a9) [**Tigermed announced it will participate in the privatization and business split of Frontage Holdings through its wholly-owned subsidiary Hong Kong Tigermed.**瑞銀 · statement](https://dgw.tmarket.io/claims/01a1e74c-c273-757f-bc30-201db5377830)

[All claims](https://dgw.tmarket.io/claims)

```json
{"@context":"https://schema.org","@graph":[{"@id":"https://dgw.tmarket.io/#website","@type":"WebSite","description":"Decisions, events and falsifiable forecasts — every claim cited to its public source. Read free.","name":"DecisionGateway","url":"https://dgw.tmarket.io/","publisher":{"@id":"https://dgw.tmarket.io/#identity"}},{"@id":"https://dgw.tmarket.io/claims/01a1e96c-97ee-7e95-a08b-78d7b30f2e7c#webpage","@type":"WebPage","description":"statement by post author, recorded 2026-11-11 — verbatim quote and source citation.","name":"港怡醫院和香港中文大學醫院正在以組織碎化技術進行胰臟癌臨床試驗。 — post author — DecisionGateway","url":"https://dgw.tmarket.io/claims/01a1e96c-97ee-7e95-a08b-78d7b30f2e7c","breadcrumb":{"@id":"https://dgw.tmarket.io/claims/01a1e96c-97ee-7e95-a08b-78d7b30f2e7c#breadcrumb"},"isPartOf":{"@id":"https://dgw.tmarket.io/#website"},"potentialAction":[{"@type":"ReadAction","target":["https://dgw.tmarket.io/claims/01a1e96c-97ee-7e95-a08b-78d7b30f2e7c"]}]},{"@id":"https://dgw.tmarket.io/#identity","@type":"Organization","name":"DecisionGateway","url":"https://dgw.tmarket.io"},{"@id":"https://dgw.tmarket.io/claims/01a1e96c-97ee-7e95-a08b-78d7b30f2e7c#breadcrumb","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","name":"Home","item":"https://dgw.tmarket.io","position":1},{"@type":"ListItem","name":"Claims","item":"https://dgw.tmarket.io/claims","position":2},{"@type":"ListItem","name":"港怡醫院和香港中文大學醫院正在以組織碎化技術進行胰臟癌臨床試驗。","position":3}]},{"@id":"https://dgw.tmarket.io/claims/01a1e96c-97ee-7e95-a08b-78d7b30f2e7c#/schema/quotation/1","@type":"Quotation","dateCreated":"2026-11-11","isBasedOn":"https://t.me/rthk_new_c/401274","text":"港怡醫院和香港中文大學醫院正在以組織碎化技術進行胰臟癌臨床試驗","url":"/claims/01a1e96c-97ee-7e95-a08b-78d7b30f2e7c"}]}
```

## Sitemap

See the full [sitemap](https://dgw.tmarket.io/sitemap.md) for all pages.
